V024-1180 Screening compound: N-cyclohexyl-5-({6-[2-(4-methylphenoxy)acetyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl}methyl)furan-2-carboxamide

V024-1180 Screening compound: N-cyclohexyl-5-({6-[2-(4-methylphenoxy)acetyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl}methyl)furan-2-carboxamide
V024-1180 Screening compound: N-cyclohexyl-5-({6-[2-(4-methylphenoxy)acetyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl}methyl)furan-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V024-1180
N-cyclohexyl-5-({6-[2-(4-methylphenoxy)acetyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl}methyl)furan-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V024-1180

Molecular Formula

C29H30N2O6 (C29 H30 N2 O6)

Compound Name

N-cyclohexyl-5-({6-[2-(4-methylphenoxy)acetyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl}methyl)furan-2-carboxamide

IUPAC name

N-cyclohexyl-5-({6-[2-(4-methylphenoxy)acetyl]-3-oxo-34-dihydro-2H-14-benzoxazin-4-yl}methyl)furan-2-carboxamide

SMILES

Cc(cc1)ccc1OCC(c(cc1)cc(N2Cc3ccc(C(NC4CCCCC4)=O)o3)c1OCC2=O)=O

InChI

InChI=1S/C29H30N2O6/c1-19-7-10-22(11-8-19)35-17-25(32)20-9-13-26-24(15-20)31(28(33)18-36-26)16-23-12-14-27(37-23)29(34)30-21-5-3-2-4-6-21/h7-15,21H,2-6,16-18H2,1H3,(H,30,34)

InChI Key

UAIAGNRAQHBQDI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19890267

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

502.57

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.775

Distribution Coefficient, logD

4.775

Water Solubility, LogSw

-4.58

Polar Surface Area

76.523

Acid Dissociation Constant (pKa)

14.80

Base Dissociation Constant (pKb)

5.58

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.50

V024-1180 in Drug Discovery

Included in Screening Libraries

ACE2 Library (3043 compounds)

CORONAVIRUS Library (20774 compounds)

GABA Library (7115 compounds)

Lipid Metabolism Library (9174 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Eye
  • Cardiovascular
  • Metabolic
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V024-1180 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V024-1180?
Check Price and Availability of V024-1180, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V024-1180 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V024-1180
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V024-1180
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V024-1180 available by request